Market Research Reports

Heparin Market - Global Industry Size, Market Share Trends, Analysis And Forecast 2012 - 2018

 

Description



Heparin is widely used as an anticoagulant and is a sulfated glycosaminoglycan. It is produced by mast cells and basophils and is a naturally occurring anti-coagulant. In 2011, the global market for heparin is expected to grow at a CAGR of 12% from 2012 to 2018.

Increasing focus on research and development initiatives by the drug manufacturers, lift of export standards for heparin and global aging population are the three most prominent growth drivers for the market. Rise in the healthcare expenditure and research in emerging economies especially China and the presence of a strong pipeline exploring new application areas for heparin, are some of the future growth opportunities for the market. 

The global heparin market can be segmented on the basis of types into heparin and low molecular weight heparin. The low molecular weight heparin market can be further segmented into dalteparin, enoxaparin and tinzaparin. All these low molecular weight heparins have applications in disease segments such as deep vein thrombosis, pulmonary embolism, renal impairment and hemodialysis. The heparin market can also be segmented on the basis of end users into laboratories, hospitals, emergency medical centers and medical practitioner offices. The geographic segmentation of the market includes the North American, European, Asian and the rest of the world regions. 

The dalteparin market held the majority of the market share in 2011, followed by the tinzaparin market. The North American heparin market, led the market in terms of market share in 2011. Increase in the exports of heparin by China, post the lifting of heparin export standard and the economic growth in countries such as India, will help the Asian heparin market grow at the fastest growth rate during the forecast period. 

The key players of the market are Sanofi, Baxter Healthcare, Pfizer Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Co., Leo Pharma Inc. and others 

Table of Contents


TABLE OF CONTENT

1. Preface
    1.1. Report Description
    1.2. Research Methodology
    1.3. Market Segmentation
    1.4. List of Acronyms

2. Executive Summary

3. Global Heparin Market Overview
    3.1. Market Trends and Future Outlook, 2010 - 2018
    3.2. Growth Drivers
           3.2.1. Impact Analysis of the Growth Drivers
    3.3. Growth Restraints
           3.3.1. Impact Analysis of the Growth Restraints
    3.4. Growth Opportunities
           3.4.1. Impact Analysis of the Growth Opportunities
    3.5. Porter’s Five Forces Analysis for the Heparin Market
    3.6. Pipeline and New Product Analysis

4. Global Heparin Market, by Types, Market Size and Forecast, 2010 – 2018 (USD Million)
    4.1. Heparin Market
    4.2. Low Molecular Weight Heparin Market
          4.2.1. Dalteparin
          4.2.2. Enoxaparin
          4.2.3. Tinzaparin 

5. Global Heparin Market, by Application Areas, Market Size and Forecast, 2010 – 2018 (USD Million)
    5.1. Dalteparin
           5.1.1. Deep Vein Thrombosis (DVT)
           5.1.2. Pulmonary Embolism
           5.1.3. Hemodialysis
           5.1.4. Renal Impairment
           5.1.5. Venous Thromboembolism (VTE)
    5.2. Enoxaparin
           5.2.1. Deep Vein Thrombosis (DVT)
           5.2.2. Pulmonary Embolism
           5.2.3. Hemodialysis
           5.2.4. Renal Impairment
           5.2.5. Angina Blood Vessel Complications
    5.3. Tinzaparin
           5.3.1. Deep Vein Thrombosis (DVT)
           5.3.2. Pulmonary Embolism
           5.3.3. Hemodialysis
           5.3.4. Renal Impairment

6. Global Heparin Market, by End-Users, Market Size and Forecast, 2010 – 2018 (USD Million)
    6.1. Laboratories
    6.2. Hospitals
    6.3. Emergency Care Centers
    6.4. Medical Practitioner Offices

7. Global Heparin Market, by Geography, Market Size and Forecast, 2010 – 2018 (USD Million)
    7.1. Overview
    7.2. North American Heparin Market
           7.2.1. Dalteparin
           7.2.2. Enoxaparin
           7.2.3. Tinzaparin
    7.3. European Heparin Market
           7.3.1. Dalteparin
           7.3.2. Enoxaparin
           7.3.3. Tinzaparin
    7.4. Asia Pacific Heparin Market
           7.4.1. Dalteparin
           7.4.2. Enoxaparin
           7.4.3. Tinzaparin
    7.5. Rest of the World
           7.5.1. Dalteparin
           7.5.2. Enoxaparin
           7.5.3. Tinzaparin

8. Competitive Landscape
    8.1. Market share by Key Players, 2011
    8.2. Competitive strategy by Key Players

9. Recommendations
    9.1. Market Strategy for Success
    9.2. Barriers to be Considered

10. Company Profiles
      10.1. Bristol-Myers Squibb Co.
      10.2. Leo Pharma Inc.
      10.3. Celgene Corp.
      10.4. Baxter Healthcare Corp.
      10.5. Pfizer Inc.
      10.6. Mitsubishi Tanabe Pharma Corp.
      10.7. Sanofi S.A.
      10.8. GlaxoSmithKline PLC

Enquiry Before Buying


 
Pre Book Price: $4315.5 Original Price: $4795
Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research